Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | AHR | P35869 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29829350 | 1.00 | CYP1A2 (0.55) | CYP1A2CYP2A6CYP3A4NR4A2ALDH1A1 | |
| SCHEMBL10626226 | 0.79 | CYP2A6 (0.55) | CYP1A2CYP2A6NR4A2ALDH1A1MAPT | |
| SCHEMBL29720333 | 0.77 | CYP2A6 (0.48) | CYP1A2CYP2A6CYP3A4ALDH1A1MAPT | |
| SCHEMBL5488191 | 0.77 | CYP2A6 (0.48) | CYP1A2CYP2A6CYP3A4ALDH1A1MAPT | |
| SCHEMBL6684714 | 0.77 | HSD17B10 (0.48) | CYP1A2CYP2A6CYP3A4ALDH1A1MAPT | |
| SCHEMBL11797439 | 0.77 | CYP2A6 (0.43) | CYP1A2CYP2A6ALDH1A1MAPTAHR | |
| SCHEMBL147819 | 0.75 | MAOA (0.58) | CYP1A2CYP2A6ALDH1A1MAPTHSD17B10 | |
| SCHEMBL29440644 | 0.75 | MAOA (0.58) | CYP1A2CYP2A6ALDH1A1MAPTHSD17B10 | |
| SCHEMBL10040170 | 0.74 | CYP1A2 (0.50) | CYP1A2CYP2A6CYP3A4NR4A2ALDH1A1 | |
| SCHEMBL553501 | 0.74 | ALDH1A1 (0.59) | CYP1A2CYP2A6CYP3A4ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552901-B2 | Polyarylene sulfide production method | KUREHA CORPORATION (JP) | 2026-02-17 | — | — | US | disclosed |
| US-12509555-B2 | Method for producing polyarylene sulfide | KUREHA CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-20230192958-A1 | POLYARYLENE SULFIDE PRODUCTION METHOD | KUREHA CORPORATION (JP) | 2023-06-22 | — | — | US | disclosed |
| US-20230033026-A1 | METHOD FOR PRODUCING POLYARYLENE SULFIDE | KUREHA CORPORATION (JP) | 2023-02-02 | — | — | US | disclosed |
| CN-115485320-A | Method for producing polyarylene sulfide | 株式会社吴羽 | 2022-12-16 | — | — | CN | disclosed |
| CN-114787241-A | Method for producing polyarylene sulfide | 株式会社吴羽 | 2022-07-22 | — | — | CN | disclosed |
| WO-2021131985-A1 | METHOD FOR PRODUCING POLYARYLENE SULFIDE | 株式会社クレハ | 2021-07-01 | — | — | WO | disclosed |
| US-10793584-B2 | Naphthobischalcogenadiazole derivative and production method therefor | OSAKA UNIVERSITY (JP) | 2020-10-06 | — | — | US | disclosed |
| US-20190337966-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | OSAKA UNIVERSITY (JP) | 2019-11-07 | — | — | US | disclosed |
| EP-3564245-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | Osaka University (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-0087045-A1 | Process for preparing polyarylenesulphides with increased thermal and chemical resistance and improved quality of colour | BAYER AG (DE) | 1983-08-31 | — | — | EP | disclosed |
| EP-0087046-A1 | Process for preparing polyarylenesulphides with increased thermal and chemical resistance | BAYER AG (DE) | 1983-08-31 | — | — | EP | disclosed |
| EP-0023314-B1 | PROCESS FOR PREPARING POLY(ARYLENE SULFIDES) | BAYER AG (DE) | 1983-07-20 | — | — | EP | disclosed |
| US-4362864-A | Process for the preparation of polyarylene sulphides | BAYER AKTIENGESELLSCHAFT (DE) | 1982-12-07 | — | — | US | disclosed |
| EP-0065689-A1 | Method of producing poly(arylene sulfides) | BAYER AG (DE) | 1982-12-01 | — | — | EP | disclosed |
| US-4331801-A | Process for the preparation of polyarylene sulphides | BAYER AKTIENGESELLSCHAFT (DE) | 1982-05-25 | — | — | US | disclosed |
| EP-0040747-A2 | Process for preparing polyarylene sulfides | BAYER AG (DE) | 1981-12-02 | — | — | EP | disclosed |
| US-4303781-A | Process for the preparation of polyarylene sulphides | BAYER AKTIENGESELLSCHAFT (DE) | 1981-12-01 | — | — | US | disclosed |
| EP-0023313-A1 | Process for preparing poly(arylene sulfides) | BAYER AG (DE) | 1981-02-04 | — | — | EP | disclosed |
| EP-0023314-A1 | Process for preparing poly(arylene sulfides) | BAYER AG (DE) | 1981-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793584-B2 | Naphthobischalcogenadiazole derivative and production method therefor | CYP24A1, CYP26B1, CYP21A2 | CYP1A2 115/4885CYP2A6 96/4885CYP3A4 389/4885 |
| US-20190337966-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | CYP24A1, CYP26B1, CYP21A2 | CYP1A2 115/4885CYP2A6 96/4885CYP3A4 389/4885 |
| US-12509555-B2 | Method for producing polyarylene sulfide | AS3MT, ZW10, POLR2H | CYP1A2 2061/4885CYP2A6 3455/4885CYP3A4 1187/4885 |
| US-12552901-B2 | Polyarylene sulfide production method | PEAK1, POLR2H, TDO2 | CYP1A2 704/4885CYP2A6 1765/4885CYP3A4 604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.